Dose‐dependent association of apolipoprotein e allele ε4 with late‐onset, sporadic Alzheimer's disease
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
We examined the apolipoprotein E (apo E) genotypes in 47 patients with late‐onset sporadic Alzheimer's disease (mean age at onset ± standard deviation, 72.2 ± 6.4 years), 8 with late‐onset familial Alzheimer's disease (75.5 ± 5.1 years), 18 with early‐onset sporadic Alzheimer's disease (52.8 ± 4.7 years), and 10 with early‐onset familial Alzhemer's disease (52.0 ± 6.8 years) in Japan and compared them with genotypes in control subjects. In late‐onset sporadic Alzheimer's disease, apo E‐ε4 frequency increased significantly (ε4 frequency: 0.34 vs 0.095 in controls, p < 0.0001), and the odds ratio, which represents the strength of association between Alzheimer's disease and apo E‐ε4 gene (3 [95% confidence interval, 2–6] in one dose; 43 [95% confidence interval, 12–154] in two doses). This study also suggested that apo E‐ε4 is associated with both late‐onset (ε4: 0.31) and early‐onset familial Alzheimer's disease (ε4: 0.35). In contrast, we found no association between apo E‐ε4 and early‐onset sporadic Alzheimer's disease (ε4: 0.08). These results indicate that the risk of developing late‐onset sporadic Alzheimer's disease is markedly dependent on the dose of apo E‐ε4, while apo E‐ε4 does not appear to be a major risk factor for early‐onset sporadic Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J., Farlow, M., Ghetti, B., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,127
Apolipoprotein E polymorphism and Alzheimer's disease
Poirier, J., Bertrand, P., Poirier, J., Kogan, S., Gauthier, S., Poirier, J., Gauthier, S., Davignon, J., Bouthillier, D., & Davignon, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91705-q · Cited by 1,108
Cited by
The Cambridge Handbook of Age and Ageing
(2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511610714 · Cited by 336
Saunders, A., Hulette, C., Welsh-Bohmer, K., Schmechel, D., Crain, B., Burke, Jr., Alberts, M., Strittmatter, W., Breitner, J., Rosenberg, C., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01251-2 · Cited by 253
ApoE4 Decreases Spine Density and Dendritic Complexity in Cortical Neurons In Vivo
Dumanis, S. B., Tesoriero, J. A., Babus, L. W., Nguyen, M. T., Trotter, J. H., Ladu, M. J., Weeber, E. J., Turner, R. S., Xu, B., Rebeck, G. W., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4026-09.2009 · Cited by 220
“The 4 allele increases the risk for developing AD (Rebeck et al., 1993; Strittmatter et al., 1993; Yoshizawa et al., 1994), while the 2 allele decreases this risk (Poirier et al.”
BackgroundQuantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease.
(1998) · Europe PMC (PubMed Central) · Cited by 145
Morishima-Kawashima, M., Oshima, N., Ogata, H., Yamaguchi, H., Yoshimura, M., Sugihara, S., & Ihara, Y. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64847-x · Cited by 119
“These figures are similar to those reported for the populations of Europe and North America,(2) and the frequency of the e4 allele is somewhat higher than that in the general Japanese population (;9%).(23,24)”
Result
Metadata
- Authors
- Yoshizawa, T., Yamakawa‐Kobayashi, K., Komatsuzaki, Y., Arinami, T., Oguni, E., Mizusawa, H., Shoji, S., & Hamaguchi, H.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1994-10
- Volume
- 36
- Issue
- 4
- Pages
- 656-659
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2108048131
- Cited by
- 71
- References
- 3
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.